GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
P

Petlife Pharmaceuticals PTLF · USD

N/A · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

Price performance

Chart by TradingView, with its own licensed prices

Petlife Pharmaceuticals — daily PTLF Delayed
Market value
$19,675
Last close × shares
Volume
500
Shares, 30 Oct 2026

About Petlife Pharmaceuticals

Its shares trade under the ticker PTLF.

Petlife Pharmaceuticals, Inc. engages in the research, development, sales, and support of drugs and nutraceuticals for pet cancer and autoimmune related diseases. The company is headquartered in Los Angeles, California. The firm specializes in the research, development, sales and support of drugs and nutraceuticals for pet cancer and autoimmune related diseases, such as arthritis. The firm has developed and is launching veterinary cancer medications and nutraceuticals, based on the Escozine formula. The firm has rights to formulate, package and market a product line, Vitalzul. Vitalzul is a polarized, bioactive peptide extracted from the Blue Caribbean Scorpion (Rhopularus Princeps), which contains amino acids, proteins and minerals. Vitalzul inhibits blood vessels formation in solid tumors. Escozine has been used in combination with chemotherapy, radiation, hormone therapy and other conventional treatments. As of August 31, 2016, Escozine (for humans) was sold as either a nutraceutical or prescription drug in 40 countries, including the United States.

Figures and description from our data supplier, not checked against the company's own report.

More about Petlife Pharmaceuticals →

Latest on Petlife Pharmaceuticals

Our reporting

We have not reported on Petlife Pharmaceuticals yet.

Other N/A listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Petlife Pharmaceuticals's ticker?

Petlife Pharmaceuticals trades as PTLF on its US listing, under ISIN US71639C1036.

What was Petlife Pharmaceuticals's last closing price?

0.00 on 30 Oct 2026. The figure is in USD and is never converted.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.